C-reactive protein and fibrinogen of bedridden older patients in a six-month vitamin d supplementation trial

Journal of Nutrition, Health and Aging

Volumn 13, Issue 5, 2009, Pages 435-439

  Bjorkman, M P ^a   Sorva, A J ^b   Tilvis, R S ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b Helsinki City Health Center   (Finland)

Author keywords

Acute phase response; Aged; C reactive protein; Fibrinogen; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; C REACTIVE PROTEIN; CALCIUM CARBONATE; CARBOXY TERMINAL TELOPEPTIDE; COLECALCIFEROL; FIBRINOGEN; PARATHYROID HORMONE; PROCOLLAGEN; VITAMIN D;

ACUTE PHASE RESPONSE; AGED; ARTICLE; BONE TURNOVER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRITICAL ILLNESS; DOUBLE BLIND PROCEDURE; FEMALE; FINLAND; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VITAMIN SUPPLEMENTATION;

EID: 67649304847     PISSN: 12797707     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12603-009-0080-3     Document Type: Article

References (30)

1. Holick MR Vitamin D deficiency. N Engl J Med 2007;357:266-81.
2. Canning MO, Grotenhuis K, de Wit H, Ruwhof C, Drexhage HA. l-alpha,25-Dihydroxyvitamin D3 (1,25(OH)(2)D(3)) hampers the maturation of fully active immature dendritic cells from monocytes. Eur J Endocrinol 2001;145:351-7.
3. McCarty MF. Secondary hyperparathyroidism promotes the acute phase response - a rationale for supplemental vitamin D in prevention of vascular events in the elderly. Med Hypotheses 2005:64:1022-6.
4. Zhu Y, Mahon BD, Froicu M, Cantorna MT. Calcium and lalpha,25- dihydroxyvitamin D3 target the TNF-alpha pathway to suppress experimental inflammatory bowel disease. Eur J Immunol 2005:35:217-24.
5. Oelzner P, Miiller A, Deschner F, et al. Relationship between disease activity and serum levels of vitamin D metabolites and PTH in rheumatoid arthritis. Calcif Tissue Int 1998;62:193-8.
6. Oelzner P, Franke S, MOller A, et al. Relationship between soluble markers of immune activation and bone turnover in post-menopausal women with rheumatoid arthritis. Rheumatology (Oxford) 1999;38:841-7.
7. Lange U, Teichmann J, Strunk J, MUller-Ladner U, Schmidt KL. Association of 1.25 vitamin D3 deficiency, disease activity and low bone mass in ankylosing spondyMs. Osteoporos Int. 2005:16:1999-2004.
8. Oelzner P, Lehmann G, Eidner T, et al. Hypercalcemia in rheumatoid arthritis: relationship with disease activity and bone metabolism. Rheumatol Int 2006:26:908-15.
9. Jorde R, Haug E, Figenschau Y, Hansen JB. Serum levels of vitamin D and haemostatic factors in healthy subjects: the Tromso study. Acta Haematol 2007:117:91-97.
10. Patel S, Farragher T, Berry J, Bunn D, Silman A, Symmons D. Association between serum vitamin D metabolite levels and disease activity in patients with early inflammatory polyarthritis. Arthritis Rheum 2007:56:2143-9.
11. Targher G, Bertolini L, Padovani R, et al. Serum 25-hydroxyvitamin D3 concentrations and carotid artery intima-media thickness among type 2 diabetic patients. Clin Endocrinol (Oxf) 2006:65:593-7.
12. Timms PM, Mannan N, Hitman GA, et al. Circulating MMP9, vitamin D and variation in the T1MP-1 response with VDR genotype; mechanisms for inflammatory damage in chronic disorders? QJM 2002:95:787-96.
13. Landin-Wilhelmsen K, Wilhelmsen L, Wilske J, et al. Sunlight increases serum 25(OH) vitamin D concentration whereas 1,25(OH)2D3 is unaffected. Results from a general population study in Goteborg, Sweden (The WHO MONICA Project). Eur J Clin Nutr 1995;49:400-7.
14. Van den Berghe G, Van Roosbroeck D, Vanhove P, Wouters PJ, De Pourcq L, Bouillon R. Bone turnover in prolonged critical illness: effect of vitamin D. J Clin Endocrinol Metab 2003:88:4623-32.
15. Schleithoff SS, Zittermann A, Tenderich G, Berthold HK, Stehle P, Koerfer R. Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: a double-blind, randomized, placebo-controlled trial. Am J Clin Nutr 2006:83:754-9.
16. Gannagd-Yared MH, Azoury M, Mansour I, Baddoura R, Halaby G, Naaman R. Effects of a short-term calcium and vitamin D treatment on serum cytokines, bone markers, insulin and lipid concentrations in healthy post-menopausal women. J Endocrinol Invest 2003:26:748-53.
17. McClung MR, Sins E, Cummings S, et al. Prevention of bone loss in postmenopausal women treated with lasofoxifene compared with raloxifene. Menopause 2006:13:377-86.
18. Atteritano M, Marini H, Minutoli L, et al. Effects of the phytoestrogen genistein on some predictors of cardiovascular risk in osteopenic, postmenopausal women: a two-year randomized, double-blind, placebo-controlled study. J Clin Endocrinol Metab 2007:92:3068-75.
19. Björkman M, Sorva A, Risteli J, Tilvis R. Vitamin D supplementation has minor effects on parathyroid hormone and bone turnover markers in vitamin D deficient bedridden older patients. Age Ageing 2008:37:25-31.
20. Turpeinen U, Hohenthal U, Stenman U-H. Determination of 25-Hydroxyvitamin D in Serum by HPLC and Immunoassay. Clin Chem 2003:49:1521-4.
21. Kao PC, Grant CS, Klee GG, Khosla S. Clinical performance of parathyroid hormone immunometric assays. Mayo Clin Proc 1992:67:637-45.
22. Risteli J, Elomaa I, Niemi S, Novamo A, Risteli L. Radioimmunoassay for the pyridinoline cross-linked carboxy-terminal telopeptide of type I collagen: a new serum marker of bone collagen degradation. Clin Chem 1993:39:635-40.
23. Melkko J, Kauppila S, Niemi S, et al. Immunoassay for the intact aminoterminal propeptide of human type I procollagen (PINP). Clin Chem 1996:42:947-54.
24. Levey AS, Coresh J, Balk E, et al. National Kidney Foundation. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 2003:139:137-47.
25. Ridker PM, Cook N. Clinical usefulness of very high and very low levels of C-reactive protein across the full range of Framingham Risk Scores. Circulation 2004:109:1955-9.
26. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999:340:448-54.
27. Holick MF. Vitamin D. The underappreciated D-lightful hormone that is important for skeletal and cellular health. Curr Opin Endocrinol Diabetes 2002;9:87-98.
28. Aihara K, Azuma H, Akaike M, et al. Disruption of nuclear vitamin D receptor gene causes enhanced thrombogenicity in mice. J Biol Chem 2004:279:35798-802.
29. Aman S, Paimela L, Leirisalo-Repo M, et al. Prediction of disease progression in early rheumatoid arthritis by ICTP, RF and CRP. A comparative 3-year follow-up study. Rheumatology (Oxford) 2000:39:1009-13.
30. Nishio Y, Sato Y, Taniguchi R, et al. Cardiac troponin T vs other biochemical markers in patients with congestive heart failure. Circ J 2007;71:631-5.